Reported Earlier, Outlook Therapeutics Prices $55.0M Offering Of 55,555,556 Shares And Warrants At $0.99 Combined Price Per Share
Share
Why It Matters
Outlook Therapeutics sold millions of shares to raise $55 million, which gives them cash to spend but also means existing owners' pieces get smaller. When a company needs to sell lots of shares at a low price, it's worth watching to see what they do with that money.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.